Published in Gastroenterology on October 01, 2001
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut (2006) 9.03
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
Inflammation, atrophy, and gastric cancer. J Clin Invest (2007) 4.29
Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev (2007) 3.43
Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol (2011) 1.89
Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol (2007) 1.57
Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. J Infect Dis (2003) 1.50
Chronic tamoxifen use is associated with a decreased risk of intestinal metaplasia in human gastric epithelium. Dig Dis Sci (2013) 1.43
Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses. Am J Epidemiol (2010) 1.35
The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes (2013) 1.20
Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol (2009) 1.19
Gastric carcinogenesis. Langenbecks Arch Surg (2011) 1.08
Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results. Int J Cancer (2009) 1.06
H pylori and gastric cancer: shifting the global burden. World J Gastroenterol (2006) 1.05
The role of viral and bacterial pathogens in gastrointestinal cancer. J Cell Physiol (2008) 1.02
Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol (2010) 1.02
Trend in incidence of gastric adenocarcinoma by tumor location from 1969-2004: a study in one referral center in Iran. Diagn Pathol (2006) 0.99
Pattern-recognition receptors and gastric cancer. Front Immunol (2014) 0.95
Identification of gastric cancer risk markers that are informative in individuals with past H. pylori infection. Gastric Cancer (2012) 0.95
Diet, H pylori infection and gastric cancer: evidence and controversies. World J Gastroenterol (2007) 0.93
H. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci (2010) 0.89
DNA methylation: a marker for carcinogen exposure and cancer risk. Environ Health Prev Med (2007) 0.89
P27kip1 regulates the apoptotic response of gastric epithelial cells to Helicobacter pylori. Gut (2004) 0.88
Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma. World J Gastroenterol (2005) 0.88
H. pylori seropositivity before age 40 and subsequent risk of stomach cancer: a glimpse of the true relationship? PLoS One (2011) 0.87
Management of Helicobacter pylori infection after gastric surgery. World J Gastroenterol (2014) 0.87
Dietary quercetin intake and risk of gastric cancer: results from a population-based study in Sweden. Ann Oncol (2010) 0.86
Expression of TFF2 and Helicobacter pylori infection in carcinogenesis of gastric mucosa. World J Gastroenterol (2003) 0.86
Macroscopic extent of gastric mucosal atrophy: increased risk factor for esophageal squamous cell carcinoma in Japan. BMC Gastroenterol (2009) 0.85
Causal role of Helicobacter pylori infection in gastric cancer. World J Gastroenterol (2006) 0.84
Gastric endoscopy in the 21st century: appropriate use of an invasive procedure in the era of non-invasive testing. Dig Liver Dis (2008) 0.84
Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection. Clin Vaccine Immunol (2008) 0.84
CagA and VacA Helicobacter pylori antibodies in gastric cancer. Can J Gastroenterol (2008) 0.84
Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study. Can J Gastroenterol Hepatol (2014) 0.83
Evaluation of western blot CagA seropositivity in Helicobacter pylori-seropositive and -seronegative subjects. Clin Diagn Lab Immunol (2005) 0.83
Helicobacter pylori-infection-associated CpG island hypermethylation in the stomach and its possible association with polycomb repressive marks. Virchows Arch (2008) 0.82
Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer. World J Gastroenterol (2006) 0.81
Genetic variation in a4GnT in relation to Helicobacter pylori serology and gastric cancer risk. Helicobacter (2009) 0.80
H. pylori negative MALT lymphoma patients successfully treated with antibiotics: doubts about their H. pylori negativity. Gut (2006) 0.80
Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible? EPMA J (2010) 0.80
Interactions between CagA and smoking in gastric cancer. World J Gastroenterol (2011) 0.79
Serum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancer. World J Gastroenterol (2016) 0.79
Relation of atrophic gastritis with Helicobacter pylori-CagA(+) and interleukin-1 gene polymorphisms. World J Gastroenterol (2008) 0.79
Specific therapeutic schemes of omeprazole affect the orientation of Helicobacter pylori. Antimicrob Agents Chemother (2009) 0.79
Unexpected decrease with age of Helicobacter pylori seroprevalence among Swedish blood donors. J Clin Microbiol (2003) 0.79
Effects of different Helicobacter pylori culture filtrates on growth of gastric epithelial cells. World J Gastroenterol (2008) 0.78
Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation. Biomed Res Int (2016) 0.78
Epigenetic impact of infection on carcinogenesis: mechanisms and applications. Genome Med (2016) 0.78
Role of Helicobacter pylori in gastric cancer: Updates. World J Gastrointest Oncol (2016) 0.78
Somatic DNA Hypomethylation in H. pylori-Associated High-Risk Gastritis and Gastric Cancer: Enhanced Somatic Hypomethylation Associates with Advanced Stage Cancer. Clin Transl Gastroenterol (2015) 0.77
Two distinct etiologies of gastric cardia adenocarcinoma: interactions among pH, Helicobacter pylori, and bile acids. Front Microbiol (2015) 0.77
The best method of detecting prior Helicobacter pylori infection. World J Gastroenterol (2005) 0.77
The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer. Cell Mol Gastroenterol Hepatol (2016) 0.76
Clinical Rationale for Confirmation Testing After Treatment of Helicobacter pylori Infection: Implications of Rising Antibiotic Resistance. Gastroenterol Hepatol (N Y) (2014) 0.75
From inflammation to gastric cancer - the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases. Cell Commun Signal (2017) 0.75
Pathogenesis: Infections causing gastric cancer. Nat Microbiol (2016) 0.75
Serum Helicobacter pylori FliD antibody and the risk of gastric cancer. Oncotarget (2016) 0.75
Efficacy of Helicobacter pylori eradication for the prevention of metachronous gastric cancer after endoscopic resection for early gastric cancer. World J Gastroenterol (2014) 0.75
Eradication of H pylori for the prevention of gastric cancer. World J Gastroenterol (2006) 0.75
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell (1994) 7.39
Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science (1998) 6.99
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology (1995) 3.86
Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc Natl Acad Sci U S A (2001) 3.42
Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol (2000) 3.39
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001) 3.28
Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. Gastroenterology (2001) 3.17
Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother (1997) 2.73
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58
Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet (1983) 2.51
Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med (1994) 2.47
Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology (2001) 2.34
Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology (2001) 2.30
AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology (1998) 2.19
No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16
Venous thromboembolism and cancer. Lancet (1998) 2.08
Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06
Monoclonal antibodies for rapid identification of Campylobacter pyloridis. Lancet (1986) 2.04
Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol (1995) 2.01
No survival benefit from early-start dialysis in a population-based, inception cohort study of Swedish patients with chronic kidney disease. J Intern Med (2010) 2.01
Comparison of genetic divergence and fitness between two subclones of Helicobacter pylori. Infect Immun (2001) 1.98
Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst (1997) 1.98
Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer (1999) 1.97
Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol (1994) 1.96
Helicobacter pylori in the drinking water in Peru. Gastroenterology (1996) 1.95
Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reaction. J Clin Microbiol (1993) 1.94
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med (2000) 1.83
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med (1986) 1.79
Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer (1993) 1.75
Risk factors for oesophageal cancer in northeast China. Int J Cancer (1994) 1.73
Urease-associated heat shock protein of Helicobacter pylori. Infect Immun (1992) 1.71
The morphological transition of Helicobacter pylori cells from spiral to coccoid is preceded by a substantial modification of the cell wall. J Bacteriol (1999) 1.69
An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979-1992. Eur Heart J (1996) 1.68
Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst (1997) 1.68
Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope (1997) 1.67
Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J (1999) 1.65
Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst (1995) 1.62
Immunomagnetic separation and PCR for detection of Helicobacter pylori in water and stool specimens. J Clin Microbiol (1995) 1.62
Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations. Hum Mol Genet (1997) 1.60
Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer (1993) 1.57
Blocked and nonblocked acid secretion and reported pain in ulcer, nonulcer dyspepsia, and normal subjects. Gastroenterology (1989) 1.53
The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA (1995) 1.51
Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol (2004) 1.49
Pancreatitis and pancreatic cancer: a population-based study. J Natl Cancer Inst (1994) 1.49
Does the method of Helicobacter pylori detection influence the association with gastric cancer risk? Scand J Gastroenterol (2002) 1.46
Helicobacter pylori and acute bleeding peptic ulcer. Eur J Gastroenterol Hepatol (1995) 1.46
The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia (1999) 1.45
Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer (1999) 1.44
Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer (1997) 1.42
Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy (2014) 1.41
Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg (1993) 1.40
[Virus-specific antibody profile in various stages of HIV-1 infection. Western blot analysis of 170 patients]. Klin Wochenschr (1988) 1.38
Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population-based cohort of prostate cancer patients. Cancer Epidemiol Biomarkers Prev (1998) 1.38
Alcohol abuse and the risk of pancreatic cancer. Gut (2002) 1.35
Reproducibility and validity of a postal questionnaire. The abdominal symptom study. Scand J Prim Health Care (1993) 1.35
The risk of pancreatic cancer following pancreatitis: an association due to confounding? Gastroenterology (1997) 1.34
Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. Int J Cancer (1999) 1.33
Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur J Cancer Prev (2001) 1.31
Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. Br J Cancer (2001) 1.26
The risk of gastrointestinal and other primary malignant diseases following gastric cancer. Acta Oncol (1991) 1.26
Nutrients and gastric cancer risk. A population-based case-control study in Sweden. Int J Cancer (1994) 1.25
Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia. Gut (2003) 1.25
Incidence of cancer among patients with systemic sclerosis. Cancer (1995) 1.25
Helicobacter pylori strain types and risk of gastric cancer: a case-control study. Cancer Epidemiol Biomarkers Prev (2000) 1.24
Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer (2000) 1.23
Appendectomy in Sweden 1989-1993 assessed by the Inpatient Registry. J Clin Epidemiol (1998) 1.22
The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population. A report from the Abdominal Symptom Study. Scand J Gastroenterol (1994) 1.22
Survival in stomach cancer is improving: results of a nationwide population-based Swedish study. Ann Surg (1999) 1.22
Identification and characterization of Mycobacterium paratuberculosis recombinant proteins expressed in E. coli. Curr Microbiol (1994) 1.19
Nationwide study of cancer risk among hip replacement patients in Sweden. J Natl Cancer Inst (2001) 1.19
Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case-control study in Sweden. Int J Cancer (2000) 1.18
Early-life risk indicators of gastric cancer. A population-based case-control study in Sweden. Int J Cancer (1994) 1.17
Influence of mutation type and location on phenotype in 123 patients with Rett syndrome. Neuropediatrics (2002) 1.17
A population-based binational register for monitoring long-term outcome and possible disease concordance among blood donors and recipients. Vox Sang (2006) 1.17
Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma. Vox Sang (2009) 1.16
IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer (1996) 1.16
The diagnostic value of enzyme immunoassay and immunoblot in monitoring eradication of Helicobacter pylori. Scand J Infect Dis (1997) 1.14
Validation of an Inguinal Pain Questionnaire for assessment of chronic pain after groin hernia repair. Br J Surg (2008) 1.13
Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine. Nitric Oxide (2001) 1.13
Colorectal cancer after cholecystectomy: absence of risk increase within 11-14 years. Gastroenterology (1983) 1.12
Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden. J Natl Cancer Inst (1999) 1.11
Brachyspira aalborgi infection diagnosed by culture and 16S ribosomal DNA sequencing using human colonic biopsy specimens. J Clin Microbiol (2000) 1.11
Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer (2000) 1.11
Presence of Helicobacter species DNA in Swedish water. J Appl Microbiol (1998) 1.10